previous compound ID: 239 next compound
InChIKey: BJRNKVDFDLYUGJ-RMPHRYRLSA-N
SMILES: C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "SD Macknight" "J Goepp" "D Rotin" "B Kus" "E Matthes" "JW Hanrahan" "R Robert" "J Liao" "DY Thomas"

chemical graph of compound 239





CID is 440936
synonyms found at PubChem are:
arbutin, 497-76-7, Uvasol, p-Arbutin, Ursin, beta-Arbutin, 4-Hydroxyphenyl beta-D-glucopyranoside, Arbutoside, Arbutine, Arbutyne, Ursi, p-Hydroxyphenyl beta-D-glucoside, p-Hydroxyphenyl beta-D-glucopyranoside, UNII-C5INA23HXF, Hydroquinone-O-beta-D-glucopyranoside, Hydroquinone |A-D-glucopyranoside, C5INA23HXF, 4-Hydroxyphenyl-beta-D-glucopyranoside, CHEMBL232202, CHEBI:18305, Hydroquinone beta-D-glucopyranoside, hydroquinone O-beta-D-glucopyranoside, 4-Hydroxyphenyl-.beta.-D-glucopyranoside, Hydroquinone-beta-D-glucopyranoside, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol, DSSTox_CID_20152, DSSTox_RID_79450, DSSTox_GSID_40152, C12H16O7, Hydroquinone glucose, NSC 4036, EINECS 207-850-3, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)tetrahydropyran-3,4,5-triol, BRN 0089673, CAS-497-76-7, Uva, SR-05000002157, CCRIS 9273, HSDB 7661, NCGC00095599-01, beta-D-Glucopyranoside, 4-hydroxyphenyl, Spectrum_000786, SpecPlus_000314, Arbutin, >=98%, Prestwick3_001026, Spectrum2_000662, Spectrum3_001233, Spectrum4_001474, Spectrum5_000147, bmse000365, Arbutin (Uva, p-Arbutin), Arbutin, analytical standard, SCHEMBL36351, Arbutin - Uva - p-Arbutin, BSPBio_001211, BSPBio_002706, Hydroquinone-beta-D-glucoside, KBioGR_002047, KBioSS_001266, SPECTRUM300539, 5-17-07-00110 (Beilstein Handbook Reference), MLS002207046, DivK1c_006410, SPBio_000723, AC1L9A87, BPBio1_001333, MEGxp0_001504, DTXSID7040152, KBio1_001354, KBio2_001266, KBio2_003834, KBio2_006402, KBio3_002206, hydroquinone O--D-glucopyranoside, BJRNKVDFDLYUGJ-RMPHRYRLSA-N, MolPort-001-742-322, HMS2098M13, HMS3715M13, ZINC518554, HY-N0192, 4-Hydroxyphenyl-beta-glucopyranoside, Tox21_111509, Tox21_302428, BDBM50219502, CA0139, CCG-38565, DT1742, GC0919, MFCD00016915, s2263, AKOS015965305, Tox21_111509_1, CS-3084, DB11217, KS-5252, RP29659, SDCCGMLS-0066538.P001, KS-00000L08, SMP1_000028, NCGC00166076-02, NCGC00166076-03, NCGC00166076-04, NCGC00166076-07, NCGC00255705-01, AC-20183, SMR001233417, TR-012619, A0522, AB00443586, FT-0622464, N1714, A-9320, C06186, beta-D-Glucopyranoside, 4-hydroxyphenyl- (9CI), 497A767, Arbutin, primary pharmaceutical reference standard, Arbutin pound>>4-hydroxyphenyl-beta-d-glucopyranosid, SR-05000002157-2, SR-05000002157-4, alpha-Arbutin; 4-Hydroquinone-alpha-D-glucopyranoside, Arbutin, European Pharmacopoeia (EP) Reference Standard, 4E19B706-2013-4401-A1FC-A154DADF42B4, (2S,3R,4S,5S,6R)-2-(4-hydroxyphenoxy)-6-methylol-tetrahydropyran-3,4,5-triol, 30373-96-7, 39464-18-1